Preclinical Pharmacological Evaluation of Anisoylated Plasminogen Streptokinase Activator Complex
- 1 January 1987
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 33 (3), 33-50
- https://doi.org/10.2165/00003495-198700333-00005
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?The American Journal of Cardiology, 1987
- An Interim Report of the Efficacy and Safety of Anisoylated Plasminogen Streptokinase Activator Complex (APSAC)1Drugs, 1987
- Pharmacokinetic Properties of Anisoylated Plasminogen Streptokinase Activator Complex and Other Thrombolytic Agents in Animals and in HumansDrugs, 1987
- The Effect of Heparin and Fibrin on the Enzymatic Efficiencies of Thrombolytics in VitroDrugs, 1987
- The Protective Effect of Acylation on the Stability of Anisoylated Plasminogen Streptokinase Activator Complex in Human PlasmaDrugs, 1987
- Evidence for the Progressive Uptake of Anisoylated Plasminogen Streptokinase Activator Complex by Clots in Human Plasma in VitroDrugs, 1987
- The hypotensive effect of intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1985
- Coronary Thrombolysis for Evolving Myocardial InfarctionDrugs, 1984
- The fibrinolytic system in manCritical Reviews in Oncology/Hematology, 1984
- Fibrinolysis with acyl-enzymes: a new approach to thrombolytic therapyNature, 1981